TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs6799705
log Bayes Factor = 3.95758
Chromosome 3   position 35,982,130  (GRCh37) Explore rs6799705 on Ensembl!
Variant rs6799705 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Chapter XIX Injury, poisoning and certain other consequences of external causes
1.000 0.000 0.000
# Top node
0.998 0.002 0.000
Chapter VI Diseases of the nervous system
0.997 0.003 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.995 0.005 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.995 0.005 0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue
0.988 0.012 0.000
T93 Sequelae of injuries of lower limb
0.986 0.014 0.000
M65-M68 Disorders of synovium and tendon
0.984 0.016 0.000
Chapter V Mental and behavioural disorders
0.980 0.020 0.000
M65 Synovitis and tenosynovitis
0.979 0.021 0.000
M65.9 Synovitis and tenosynovitis, unspecified
0.976 0.024 0.000
Chapter XX External causes of morbidity and mortality
0.975 0.025 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.971 0.029 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.968 0.032 0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.964 0.036 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.963 0.037 0.000
G40-G47 Episodic and paroxysmal disorders
0.960 0.040 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.943 0.057 0.000
F41 Other anxiety disorders
0.936 0.064 0.000
T51 Toxic effect of alcohol
0.933 0.067 0.000
M50-M54 Other dorsopathies
0.926 0.074 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.924 0.076 0.000
T93.2 Sequelae of other fractures of lower limb
0.923 0.077 0.000
G20-G26 Extrapyramidal and movement disorders
0.921 0.079 0.000
T93.0 Sequelae of open wound of lower limb
0.919 0.081 0.000
M54 Dorsalgia
0.914 0.086 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.913 0.087 0.000
F45 Somatoform disorders
0.910 0.090 0.000
S50-S59 Injuries to the elbow and forearm
0.905 0.095 0.000
G40 Epilepsy
0.902 0.098 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.901 0.099 0.000
G43 Migraine
0.898 0.102 0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas
0.897 0.103 0.000
Chapter XI Diseases of the digestive system
0.892 0.108 0.000
M54.5 Low back pain
0.888 0.112 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.886 0.114 0.000
K81 Cholecystitis
0.886 0.114 0.000
Y95 Nosocomial condition
0.883 0.117 0.000
G50-G59 Nerve, nerve root and plexus disorders
0.879 0.121 0.000
F41.9 Anxiety disorder, unspecified
0.877 0.123 0.000
T51.0 Ethanol
0.874 0.126 0.000
M45-M49 Spondylopathies
0.873 0.127 0.000
M66 Spontaneous rupture of synovium and tendon
0.869 0.131 0.000
F45.8 Other somatoform disorders
0.866 0.134 0.000
K81.0 Acute cholecystitis
0.865 0.135 0.000
G81 Hemiplegia
0.863 0.137 0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.862 0.138 0.000
G43.9 Migraine, unspecified
0.861 0.139 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.859 0.141 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.857 0.143 0.000
G20 Parkinson's disease
0.856 0.144 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.854 0.146 0.000
Y57 Other and unspecified drugs and medicaments
0.854 0.146 0.000
K86 Other diseases of pancreas
0.853 0.147 0.000
S90-S99 Injuries to the ankle and foot
0.853 0.147 0.000
T79-T79 Certain early complications of trauma
0.848 0.152 0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.845 0.155 0.000
V10-V19 Pedal cyclist injured in transport accident
0.840 0.160 0.000
G82 Paraplegia and tetraplegia
0.839 0.161 0.000
T00-T07 Injuries involving multiple body regions
0.838 0.162 0.000
G80 Infantile cerebral palsy
0.835 0.165 0.000
M45 Ankylosing spondylitis
0.834 0.166 0.000
G47 Sleep disorders
0.833 0.167 0.000
M54.59 Low back pain (Site unspecified)
0.831 0.169 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.829 0.171 0.000
Y40 Systemic antibiotics
0.826 0.174 0.000
T90 Sequelae of injuries of head
0.824 0.176 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.823 0.177 0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue
0.822 0.178 0.000
M40-M43 Deforming dorsopathies
0.821 0.179 0.000
T51.9 Alcohol, unspecified
0.821 0.179 0.000
G57 Mononeuropathies of lower limb
0.816 0.184 0.000
Chapter XXII Codes for special purposes
0.815 0.185 0.000
K81.1 Chronic cholecystitis
0.813 0.187 0.000
F60-F69 Disorders of adult personality and behaviour
0.810 0.190 0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.809 0.191 0.000
F41.1 Generalised anxiety disorder
0.805 0.195 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.805 0.195 0.000
F43 Reaction to severe stress, and adjustment disorders
0.802 0.198 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.802 0.198 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
0.798 0.202 0.000
T93.8 Sequelae of other specified injuries of lower limb
0.796 0.204 0.000
G40.9 Epilepsy, unspecified
0.793 0.207 0.000
G81.9 Hemiplegia, unspecified
0.792 0.208 0.000
G50 Disorders of trigeminal nerve
0.788 0.212 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.788 0.212 0.000
M66.2 Spontaneous rupture of extensor tendons
0.786 0.214 0.000
W50-W64 Exposure to animate mechanical forces
0.781 0.219 0.000
T91 Sequelae of injuries of neck and trunk
0.781 0.219 0.000
K65-K67 Diseases of peritoneum
0.781 0.219 0.000
K85 Acute pancreatitis
0.780 0.220 0.000
S40-S49 Injuries to the shoulder and upper arm
0.779 0.221 0.000
F80-F89 Disorders of psychological development
0.779 0.221 0.000
M54.56 Low back pain (Lumbar region)
0.778 0.222 0.000
K86.3 Pseudocyst of pancreas
0.778 0.222 0.000
M54.1 Radiculopathy
0.778 0.222 0.000
S80-S89 Injuries to the knee and lower leg
0.776 0.224 0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
0.775 0.225 0.000
M65.8 Other synovitis and tenosynovitis
0.775 0.225 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.774 0.226 0.000
T93.1 Sequelae of fracture of femur
0.773 0.227 0.000
T94 Sequelae of injuries involving multiple and unspecified body regions
0.771 0.229 0.000
S92 Fracture of foot, except ankle
0.770 0.230 0.000
T56 Toxic effect of metals
0.770 0.230 0.000
M54.55 Low back pain (Thoracolumbar region)
0.767 0.233 0.000
Q80-Q89 Other congenital malformations
0.767 0.233 0.000
K82 Other diseases of gallbladder
0.766 0.234 0.000
Chapter VII Diseases of the eye and adnexa
0.765 0.235 0.000
K35-K38 Diseases of appendix
0.762 0.238 0.000
S52 Fracture of forearm
0.760 0.240 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.759 0.241 0.000
M54.4 Lumbago with sciatica
0.757 0.243 0.000
T66-T78 Other and unspecified effects of external causes
0.756 0.244 0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb
0.755 0.245 0.000
S10-S19 Injuries to the neck
0.755 0.245 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.755 0.245 0.000
Y52 Agents primarily affecting the cardiovascular system
0.753 0.246 0.000
Y57.9 Drug or medicament, unspecified
0.753 0.247 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.748 0.252 0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.746 0.254 0.000
G30-G32 Other degenerative diseases of the nervous system
0.746 0.254 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.746 0.254 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.745 0.255 0.000
M65.4 Radial styloid tenosynovitis [de Quervain]
0.743 0.257 0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.742 0.258 0.000
H30-H36 Disorders of choroid and retina
0.741 0.259 0.000
S51 Open wound of forearm
0.741 0.259 0.000
T79 Certain early complications of trauma, not elsewhere classified
0.740 0.260 0.000
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
0.740 0.260 0.000
V80-V89 Other land transport accidents
0.738 0.262 0.000
G24 Dystonia
0.736 0.264 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.734 0.266 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.733 0.267 0.000
Y40.8 Other systemic antibiotics
0.732 0.268 0.000
T58 Toxic effect of carbon monoxide
0.727 0.273 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.727 0.273 0.000
M00-M03 Infectious arthropathies
0.727 0.273 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.727 0.273 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.727 0.273 0.000
M66.24 Spontaneous rupture of extensor tendons (Hand)
0.727 0.273 0.000
G06 Intracranial and intraspinal abscess and granuloma
0.726 0.273 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.726 0.274 0.000
M86-M90 Other osteopathies
0.725 0.275 0.000
G57.6 Lesion of plantar nerve
0.724 0.276 0.000
V18 Pedal cyclist injured in noncollision transport accident
0.724 0.276 0.000
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue
0.724 0.276 0.000
G50.0 Trigeminal neuralgia
0.724 0.276 0.000
T93.9 Sequelae of unspecified injury of lower limb
0.722 0.278 0.000
K86.0 Alcohol-induced chronic pancreatitis
0.721 0.279 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.720 0.280 0.000
H36 Retinal disorders in diseases classified elsewhere
0.720 0.280 0.000
M65.1 Other infective (teno)synovitis
0.720 0.280 0.000
G41 Status epilepticus
0.718 0.282 0.000
R21 Rash and other nonspecific skin eruption
0.718 0.282 0.000
K70-K77 Diseases of liver
0.717 0.283 0.000
T33-T35 Frostbite
0.717 0.283 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.717 0.283 0.000
R70-R79 Abnormal findings on examination of blood, without diagnosis
0.717 0.283 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.716 0.284 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.716 0.284 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.713 0.286 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.713 0.286 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.713 0.286 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.713 0.286 0.000
T36 Poisoning by systemic antibiotics
0.713 0.286 0.000
G40.5 Special epileptic syndromes
0.713 0.287 0.000
T95 Sequelae of burns, corrosions and frostbite
0.713 0.287 0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source
0.713 0.287 0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances
0.713 0.287 0.000
K82.8 Other specified diseases of gallbladder
0.713 0.287 0.000
T42.1 Iminostilbenes
0.710 0.290 0.000
M60-M63 Disorders of muscles
0.710 0.290 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.708 0.292 0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.707 0.293 0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.707 0.293 0.000
T93.4 Sequelae of injury of nerve of lower limb
0.707 0.293 0.000
T42.4 Benzodiazepines
0.707 0.293 0.000
T98 Sequelae of other and unspecified effects of external causes
0.706 0.294 0.000
M68 Disorders of synovium and tendon in diseases classified elsewhere
0.706 0.294 0.000
H36.0 Diabetic retinopathy
0.705 0.295 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.704 0.296 0.000
S60-S69 Injuries to the wrist and hand
0.704 0.296 0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]
0.704 0.296 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.703 0.297 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.703 0.297 0.000
F70-F79 Mental retardation
0.703 0.297 0.000
K85.1 Biliary acute pancreatitis
0.703 0.297 0.000
M65.2 Calcific tendinitis
0.702 0.298 0.000
M65.0 Abscess of tendon sheath
0.702 0.298 0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)
0.701 0.299 0.000
G82.5 Tetraplegia, unspecified
0.701 0.299 0.000
F42 Obsessive-compulsive disorder
0.701 0.299 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.700 0.299 0.000
T46.1 Calcium-channel blockers
0.700 0.299 0.000
K65 Peritonitis
0.700 0.300 0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)
0.700 0.300 0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.700 0.300 0.000
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)
0.700 0.300 0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)
0.700 0.300 0.000
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.700 0.300 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.699 0.301 0.000
Y35-Y36 Legal intervention and operations of war
0.699 0.301 0.000
Y10-Y34 Event of undetermined intent
0.699 0.301 0.000
Y00-Y09 Assault
0.699 0.301 0.000
X85-X99 Assault
0.699 0.301 0.000
X30-X39 Exposure to forces of nature
0.699 0.301 0.000
X20-X29 Contact with venomous animals and plants
0.699 0.301 0.000
X10-X19 Contact with heat and hot substances
0.699 0.301 0.000
X00-X09 Exposure to smoke, fire and flames
0.699 0.301 0.000
W75-W84 Other accidental threats to breathing
0.699 0.301 0.000
W65-W74 Accidental drowning and submersion
0.699 0.301 0.000
V98-V99 Other and unspecified transport accidents
0.699 0.301 0.000
V95-V97 Air and space transport accidents
0.699 0.301 0.000
V90-V94 Water transport accidents
0.699 0.301 0.000
V70-V79 Bus occupant injured in transport accident
0.699 0.301 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.699 0.301 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.699 0.301 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.699 0.301 0.000
V01-V09 Pedestrian injured in transport accident
0.699 0.301 0.000
V40-V49 Car occupant injured in transport accident
0.698 0.302 0.000
F48 Other neurotic disorders
0.696 0.304 0.000
F44 Dissociative [conversion] disorders
0.696 0.304 0.000
G09 Sequelae of inflammatory diseases of central nervous system
0.696 0.304 0.000
K86.1 Other chronic pancreatitis
0.695 0.305 0.000
T65 Toxic effect of other and unspecified substances
0.694 0.306 0.000
T62 Toxic effect of other noxious substances eaten as food
0.694 0.306 0.000
T61 Toxic effect of noxious substances eaten as seafood
0.694 0.306 0.000
T60 Toxic effect of pesticides
0.694 0.306 0.000
T59 Toxic effect of other gases, fumes and vapours
0.694 0.306 0.000
T57 Toxic effect of other inorganic substances
0.694 0.306 0.000
T54 Toxic effect of corrosive substances
0.694 0.306 0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone
0.694 0.306 0.000
T52 Toxic effect of organic solvents
0.694 0.306 0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants
0.694 0.306 0.000
T55 Toxic effect of soaps and detergents
0.694 0.306 0.000
K86.2 Cyst of pancreas
0.692 0.307 0.000
M80-M85 Disorders of bone density and structure
0.692 0.308 0.000
G70-G73 Diseases of myoneural junction and muscle
0.691 0.309 0.000
K37 Unspecified appendicitis
0.691 0.309 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.690 0.309 0.000
G80.0 Spastic cerebral palsy
0.690 0.310 0.000
Y91 Evidence of alcohol involvement determined by level of intoxication
0.690 0.310 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.690 0.310 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.689 0.311 0.000
F60 Specific personality disorders
0.689 0.311 0.000
G46 Vascular syndromes of brain in cerebrovascular diseases
0.688 0.311 0.000
M54.3 Sciatica
0.688 0.311 0.000
G82.4 Spastic tetraplegia
0.688 0.312 0.000
S50 Superficial injury of forearm
0.688 0.312 0.000
G80.9 Infantile cerebral palsy, unspecified
0.687 0.313 0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)
0.685 0.315 0.000
M41 Scoliosis
0.684 0.316 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.684 0.316 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.684 0.316 0.000
S52.6 Fracture of lower end of both ulna and radius
0.683 0.317 0.000
V20-V29 Motorcycle rider injured in transport accident
0.682 0.318 0.000
S56 Injury of muscle and tendon at forearm level
0.682 0.318 0.000
T63 Toxic effect of contact with venomous animals
0.682 0.318 0.000
T90.5 Sequelae of intracranial injury
0.681 0.319 0.000
G54 Nerve root and plexus disorders
0.681 0.319 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.680 0.320 0.000
S92.0 Fracture of calcaneus
0.680 0.320 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.679 0.321 0.000
T90.2 Sequelae of fracture of skull and facial bones
0.678 0.322 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.677 0.322 0.000
X50-X57 Overexertion, travel and privation
0.677 0.323 0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.677 0.323 0.000
T01 Open wounds involving multiple body regions
0.676 0.323 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.676 0.324 0.000
Y59 Other and unspecified vaccines and biological substances
0.676 0.324 0.000
Y58 Bacterial vaccines
0.676 0.324 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.676 0.324 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.676 0.324 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.676 0.324 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.676 0.324 0.000
Y48 Anaesthetics and therapeutic gases
0.676 0.324 0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.673 0.327 0.000
R72 Abnormality of white blood cells, not elsewhere classified
0.673 0.327 0.000
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour
0.673 0.327 0.000
F41.8 Other specified anxiety disorders
0.671 0.329 0.000
F41.3 Other mixed anxiety disorders
0.671 0.329 0.000
T51.8 Other alcohols
0.669 0.331 0.000
T51.3 Fusel oil
0.669 0.331 0.000
T51.2 2-Propanol
0.669 0.331 0.000
T51.1 Methanol
0.669 0.331 0.000
F43.0 Acute stress reaction
0.668 0.332 0.000
R73 Elevated blood glucose level
0.667 0.333 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.667 0.333 0.000
T02 Fractures involving multiple body regions
0.667 0.333 0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot
0.666 0.334 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.666 0.334 0.000
M54.46 Lumbago with sciatica (Lumbar region)
0.666 0.334 0.000
M54.16 Radiculopathy (Lumbar region)
0.665 0.335 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.663 0.337 0.000
M46 Other inflammatory spondylopathies
0.663 0.337 0.000
Y40.3 Macrolides
0.663 0.337 0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level
0.662 0.338 0.000
Y98 Lifestyle-related condition
0.662 0.338 0.000
Y97 Environmental-pollution-related condition
0.662 0.338 0.000
Y96 Work-related condition
0.662 0.338 0.000
T92 Sequelae of injuries of upper limb
0.662 0.338 0.000
M54.6 Pain in thoracic spine
0.661 0.339 0.000
Y57.5 X-ray contrast media
0.661 0.339 0.000
Y57.8 Other drugs and medicaments
0.661 0.339 0.000
K80 Cholelithiasis
0.661 0.339 0.000
G23 Other degenerative diseases of basal ganglia
0.661 0.339 0.000
G21 Secondary Parkinsonism
0.661 0.339 0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.661 0.339 0.000
G22 Parkinsonism in diseases classified elsewhere
0.661 0.339 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.659 0.341 0.000
R42 Dizziness and giddiness
0.658 0.342 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.657 0.343 0.000
G57.1 Meralgia paraesthetica
0.657 0.343 0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified
0.656 0.344 0.000
M54.8 Other dorsalgia
0.655 0.344 0.000
M54.0 Panniculitis affecting regions of neck and back
0.655 0.344 0.000
T50.8 Diagnostic agents
0.654 0.345 0.000
T50.7 Analeptics and opioid receptor antagonists
0.654 0.345 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.654 0.345 0.000
T50.5 Appetite depressants
0.654 0.345 0.000
T50.4 Drugs affecting uric acid metabolism
0.654 0.345 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.654 0.345 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.654 0.345 0.000
T50.1 Loop [high-ceiling] diuretics
0.654 0.345 0.000
T50.0 Mineralocorticoids and their antagonists
0.654 0.345 0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue
0.654 0.346 0.000
G57.8 Other mononeuropathies of lower limb
0.652 0.348 0.000
F45.9 Somatoform disorder, unspecified
0.652 0.348 0.000
F45.4 Persistent somatoform pain disorder
0.652 0.348 0.000
F45.3 Somatoform autonomic dysfunction
0.652 0.348 0.000
F45.2 Hypochondriacal disorder
0.652 0.348 0.000
F45.1 Undifferentiated somatoform disorder
0.652 0.348 0.000
F45.0 Somatisation disorder
0.652 0.348 0.000
S83 Dislocation, sprain and strain of joints and ligaments of knee
0.652 0.348 0.000
S49 Other and unspecified injuries of shoulder and upper arm
0.650 0.349 0.000
S89 Other and unspecified injuries of lower leg
0.650 0.350 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.650 0.350 0.000
S59 Other and unspecified injuries of forearm
0.649 0.351 0.000
S58 Traumatic amputation of forearm
0.649 0.351 0.000
S57 Crushing injury of forearm
0.649 0.351 0.000
S55 Injury of blood vessels at forearm level
0.649 0.351 0.000
S54 Injury of nerves at forearm level
0.649 0.351 0.000
S53 Dislocation, sprain and strain of joints and ligaments of elbow
0.649 0.351 0.000
T39.0 Salicylates
0.648 0.352 0.000
M53 Other dorsopathies, not elsewhere classified
0.647 0.352 0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere
0.647 0.353 0.000
G40.8 Other epilepsy
0.647 0.353 0.000
G40.7 Petit mal, unspecified, without grand mal seizures
0.647 0.353 0.000
G40.4 Other generalised epilepsy and epileptic syndromes
0.647 0.353 0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset
0.647 0.353 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.646 0.354 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.646 0.354 0.000
T46.7 Peripheral vasodilators
0.646 0.354 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.646 0.354 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.646 0.354 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.646 0.354 0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle
0.646 0.354 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.646 0.354 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.646 0.354 0.000
S70-S79 Injuries to the hip and thigh
0.645 0.355 0.000
G83 Other paralytic syndromes
0.644 0.356 0.000
G43.8 Other migraine
0.644 0.356 0.000
G43.3 Complicated migraine
0.644 0.356 0.000
G43.2 Status migrainosus
0.644 0.356 0.000
G43.0 Migraine without aura [common migraine]
0.644 0.356 0.000
W55 Bitten or struck by other mammals
0.644 0.356 0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere
0.643 0.356 0.000
Y44 Agents primarily affecting blood constituents
0.643 0.357 0.000
V19 Pedal cyclist injured in other and unspecified transport accidents
0.643 0.357 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.642 0.358 0.000
S51.0 Open wound of elbow
0.641 0.359 0.000
X60-X84 Intentional self-harm
0.641 0.359 0.000
G47.1 Disorders of excessive somnolence [hypersomnias]
0.640 0.360 0.000
M67 Other disorders of synovium and tendon
0.640 0.360 0.000
Q50-Q56 Congenital malformations of genital organs
0.639 0.361 0.000
T17 Foreign body in respiratory tract
0.638 0.361 0.000
T23 Burn and corrosion of wrist and hand
0.637 0.363 0.000
M54.54 Low back pain-Thoracic
0.637 0.363 0.000
M54.53 Low back pain-Cervicothoracic
0.637 0.363 0.000
M54.52 Low back pain-Cervical
0.637 0.363 0.000
M54.51 Low back pain-Occipit-atl-axl
0.637 0.363 0.000
S86 Injury of muscle and tendon at lower leg level
0.637 0.363 0.000
Chapter I Certain infectious and parasitic diseases
0.636 0.364 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.635 0.365 0.000
Q35-Q37 Cleft lip and cleft palate
0.635 0.365 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.635 0.365 0.000
K81.8 Other cholecystitis
0.635 0.365 0.000
H34 Retinal vascular occlusions
0.634 0.366 0.000
F99-F99 Unspecified mental disorder
0.633 0.367 0.000
G06.1 Intraspinal abscess and granuloma
0.633 0.367 0.000
K72 Hepatic failure, not elsewhere classified
0.632 0.368 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.632 0.368 0.000
M54.50 Low back pain (Multiple sites in spine)
0.632 0.368 0.000
G53 Cranial nerve disorders in diseases classified elsewhere
0.630 0.370 0.000
G52 Disorders of other cranial nerves
0.630 0.370 0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.629 0.371 0.000
T56.8 Other metals
0.628 0.372 0.000
S52.60 Fracture of lower end of both ulna and radius (closed)
0.628 0.372 0.000
H43-H45 Disorders of vitreous body and globe
0.628 0.372 0.000
M54.2 Cervicalgia
0.627 0.373 0.000
G47.4 Narcolepsy and cataplexy
0.627 0.373 0.000
Y46.4 Iminostilbenes
0.627 0.373 0.000
Q89 Other congenital malformations, not elsewhere classified
0.626 0.374 0.000
G47.9 Sleep disorder, unspecified
0.626 0.374 0.000
M49 Spondylopathies in diseases classified elsewhere
0.626 0.374 0.000
M65.84 Other synovitis and tenosynovitis (Hand)
0.625 0.375 0.000
Q00-Q07 Congenital malformations of the nervous system
0.625 0.375 0.000
G82.2 Paraplegia, unspecified
0.624 0.376 0.000
T79.3 Post-traumatic wound infection, not elsewhere classified
0.623 0.376 0.000
G59 Mononeuropathy in diseases classified elsewhere
0.623 0.377 0.000
M66.5 Spontaneous rupture of unspecified tendon
0.623 0.377 0.000
M66.4 Spontaneous rupture of other tendons
0.623 0.377 0.000
M66.3 Spontaneous rupture of flexor tendons
0.623 0.377 0.000
M66.1 Rupture of synovium
0.623 0.377 0.000
M66.0 Rupture of popliteal cyst
0.622 0.378 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.622 0.378 0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.621 0.379 0.000
H46-H48 Disorders of optic nerve and visual pathways
0.621 0.379 0.000
S52.0 Fracture of upper end of ulna
0.621 0.379 0.000
F03 Unspecified dementia
0.620 0.380 0.000
M54.9 Dorsalgia, unspecified
0.620 0.380 0.000
G81.1 Spastic hemiplegia
0.619 0.381 0.000
G81.0 Flaccid hemiplegia
0.619 0.381 0.000
M43 Other deforming dorsopathies
0.618 0.382 0.000
S92.2 Fracture of other tarsal bone(s)
0.617 0.383 0.000
H33 Retinal detachments and breaks
0.617 0.383 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.617 0.383 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.616 0.383 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.616 0.384 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.616 0.384 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.616 0.384 0.000
T42.3 Barbiturates
0.616 0.384 0.000
T42.2 Succinimides and oxazolidinediones
0.616 0.384 0.000
T42.0 Hydantoin derivatives
0.616 0.384 0.000
M54.18 Radiculopathy (Sacral and sacrococcygeal region)
0.616 0.384 0.000
F60.9 Personality disorder, unspecified
0.616 0.384 0.000
G25 Other extrapyramidal and movement disorders
0.615 0.384 0.000
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level
0.615 0.385 0.000
S92.00 Fracture of calcaneus (closed)
0.615 0.385 0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere
0.614 0.386 0.000
G00 Bacterial meningitis, not elsewhere classified
0.614 0.386 0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis
0.614 0.386 0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere
0.614 0.386 0.000
G01 Meningitis in bacterial diseases classified elsewhere
0.614 0.386 0.000
R73.9 Hyperglycaemia, unspecified
0.614 0.386 0.000
V18.0 Driver injured in nontraffic accident
0.614 0.386 0.000
F05 Delirium, not induced by alcohol and other psychoactive substances
0.614 0.386 0.000
H18 Other disorders of cornea
0.613 0.387 0.000
T79.7 Traumatic subcutaneous emphysema
0.613 0.387 0.000
Y57.7 Vitamins, not elsewhere classified
0.612 0.388 0.000
Y57.6 Other diagnostic agents
0.612 0.388 0.000
Y57.4 Pharmaceutical excipients
0.612 0.388 0.000
Y57.3 Alcohol deterrents
0.612 0.388 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.612 0.388 0.000
Y57.1 Lipotropic drugs
0.612 0.388 0.000
Y57.0 Appetite depressants [anorectics]
0.612 0.388 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.612 0.388 0.000
T94.1 Sequelae of injuries, not specified by body region
0.611 0.389 0.000
T20 Burn and corrosion of head and neck
0.611 0.389 0.000
S98 Traumatic amputation of ankle and foot
0.611 0.389 0.000
S97 Crushing injury of ankle and foot
0.611 0.389 0.000
S96 Injury of muscle and tendon at ankle and foot level
0.611 0.389 0.000
S95 Injury of blood vessels at ankle and foot level
0.611 0.389 0.000
S94 Injury of nerves at ankle and foot level
0.611 0.389 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.611 0.389 0.000
R76 Other abnormal immunological findings in serum
0.610 0.390 0.000
T39.1 4-Aminophenol derivatives
0.610 0.390 0.000
K73 Chronic hepatitis, not elsewhere classified
0.609 0.391 0.000
Q85 Phakomatoses, not elsewhere classified
0.609 0.391 0.000
K65.9 Peritonitis, unspecified
0.609 0.391 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.609 0.391 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.607 0.393 0.000
F81 Specific developmental disorders of scholastic skills
0.606 0.393 0.000
M91-M94 Chondropathies
0.606 0.394 0.000
G24.9 Dystonia, unspecified
0.603 0.397 0.000
S99 Other and unspecified injuries of ankle and foot
0.603 0.397 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.602 0.397 0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle
0.602 0.397 0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle
0.602 0.397 0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus
0.602 0.397 0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van
0.602 0.397 0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle
0.602 0.397 0.000
V11 Pedal cyclist injured in collision with other pedal cycle
0.602 0.397 0.000
V10 Pedal cyclist injured in collision with pedestrian or animal
0.602 0.397 0.000
T91.3 Sequelae of injury of spinal cord
0.602 0.398 0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere
0.602 0.398 0.000
G82.3 Flaccid tetraplegia
0.602 0.398 0.000
G82.0 Flaccid paraplegia
0.602 0.398 0.000
G58 Other mononeuropathies
0.602 0.398 0.000
T06 Other injuries involving multiple body regions, not elsewhere classified
0.601 0.399 0.000
T05 Traumatic amputations involving multiple body regions
0.601 0.399 0.000
T04 Crushing injuries involving multiple body regions
0.601 0.399 0.000
T03 Dislocations, sprains and strains involving multiple body regions
0.601 0.399 0.000
T00 Superficial injuries involving multiple body regions
0.601 0.399 0.000
T07 Unspecified multiple injuries
0.601 0.399 0.000
S90 Superficial injury of ankle and foot
0.600 0.399 0.000
Q60-Q64 Congenital malformations of the urinary system
0.600 0.400 0.000
T91.1 Sequelae of fracture of spine
0.599 0.401 0.000
F40 Phobic anxiety disorders
0.599 0.401 0.000
H20 Iridocyclitis
0.599 0.401 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.